The need for spirometry before physicians can write an Afrezza prescription has been cited by analysts as an impediment to broader use of the inhaled insulin. Rarely does a new therapy generate as ...
Afrezza (insulin human) is prescribed to manage blood sugar levels in adults with diabetes. The drug can cause side effects that range from mild to serious. Examples include low blood sugar levels and ...
Paris and Valencia, Calif. – February 3, 2015 – Sanofi and MannKind Corporation announced today that Afrezza ® (insulin human) Inhalation Powder, the only inhaled insulin, is now available by ...
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a biopharmaceutical company dedicated to transforming chronic disease care through ...
The CEO said the changes will finally allow the company to set the inhaled insulin apart from its rivals. FDA has granted MannKind Corp. a label change for the inhaled mealtime insulin, Afrezza, that ...
Forbes contributors publish independent expert analyses and insights. I write about the science behind healthcare companies. Unfortunately, the article was completely lacking in any specific ...
VALENCIA, Calif., April 27, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (MNKD) today announced that it will begin to manufacture a 12 unit cartridge strength of AFREZZA (insulin human) Inhalation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results